LANZA, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 9.869
EU - Europa 3.148
AS - Asia 1.992
OC - Oceania 11
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
Totale 15.035
Nazione #
US - Stati Uniti d'America 9.847
PL - Polonia 1.069
CN - Cina 826
IT - Italia 562
SG - Singapore 534
UA - Ucraina 534
DE - Germania 343
TR - Turchia 267
GB - Regno Unito 259
ID - Indonesia 169
FI - Finlandia 131
VN - Vietnam 119
SE - Svezia 111
FR - Francia 49
BE - Belgio 22
CA - Canada 22
HK - Hong Kong 21
RU - Federazione Russa 15
IN - India 14
JP - Giappone 14
CZ - Repubblica Ceca 13
ES - Italia 12
AU - Australia 7
LT - Lituania 7
TW - Taiwan 6
IR - Iran 5
BG - Bulgaria 4
EU - Europa 4
IL - Israele 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
AT - Austria 3
MA - Marocco 3
MD - Moldavia 3
NL - Olanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BR - Brasile 2
DZ - Algeria 2
GR - Grecia 2
IE - Irlanda 2
MY - Malesia 2
RO - Romania 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
IQ - Iraq 1
KR - Corea 1
LK - Sri Lanka 1
NO - Norvegia 1
Totale 15.035
Città #
Fairfield 1.508
Woodbridge 1.119
Warsaw 1.066
Houston 931
Ashburn 639
Jacksonville 622
Wilmington 617
Seattle 563
Chandler 537
Ann Arbor 517
Cambridge 487
Singapore 379
Princeton 312
Izmir 186
Nanjing 186
Beijing 172
Milan 172
Jakarta 167
San Diego 156
Dong Ket 115
Boardman 78
Nanchang 61
Shanghai 58
Shenyang 57
Santa Clara 53
Falls Church 50
New York 46
London 45
Redwood City 45
Bremen 44
Hebei 39
Ferrara 38
Norwalk 35
Changsha 33
Jiaxing 33
Mountain View 31
Tianjin 25
Dearborn 22
Hong Kong 21
Brussels 20
Kunming 20
Los Angeles 20
Rome 20
Jinan 19
Zhengzhou 17
San Mateo 16
Chicago 15
Helsinki 14
Ningbo 14
Addison 13
Guangzhou 13
Redmond 11
Faenza 10
Orange 10
Taizhou 10
Washington 10
Wuhan 10
Auburn Hills 9
Brno 9
Lanzhou 9
Toronto 9
Verona 9
Hounslow 8
Kilburn 8
Parma 8
Bologna 7
Chiswick 7
Des Moines 7
Düsseldorf 7
Hamilton 7
Haikou 6
Munich 6
Naples 6
Saint Louis 6
Augusta 5
Florence 5
Mestre 5
Siena 5
Tokyo 5
Acton 4
Barcelona 4
Genoa 4
Hangzhou 4
Ho Chi Minh City 4
Monmouth Junction 4
Ottawa 4
Parabiago 4
Philadelphia 4
Springfield 4
Tappahannock 4
Arcadia 3
Auckland 3
Bangalore 3
Casapesenna 3
Chisinau 3
Forest City 3
Indiana 3
Messina 3
Monselice 3
Nazareth 3
Totale 11.754
Nome #
Predictive value of hematological and phenotypical parameters on postchemotherapy leukocyte recovery 212
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 193
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 188
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 170
PCR con primer degenerati non evidenza sequenze virali di HHV8 nè di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 154
Identification of Chlamydia trachomatis in a patient with ocular lymphoma 148
null 142
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 142
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 138
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 137
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 132
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 129
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia 129
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 127
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 126
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 126
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 124
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 121
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 119
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 118
CD34+ cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation 117
RABBIT IgG ANTIBODIES AGAINST CORD RED BLOOD CELL MEMBRANES BIND TO COMPLEMENT RECEPTOR 1 (CD35) 116
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease 112
Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinical-biological features. 111
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia 109
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 108
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells 106
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 105
CXCR-4 Expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies 104
Immunosuppressive properties of mesenchymal stromal cells 103
CD34+CD33+ blast cells: Correlation with FAB subtypes 101
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach 101
CD34 quantitative flow cytometry study of the blastic population in acute leukemias. 99
BCR-ABL rearrangement is not detectable in essential thrombocythemia 99
Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics 99
Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts 97
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 95
Study of prognosis in acute myeloid leukemias (AML) by cluster analysis. 93
CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review 92
PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients 91
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 91
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia 90
Autologous stem cell transplantation: is it still relevant in breast cancer? 87
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 87
Studio dei progenitori emopoietici circolanti in pazienti con infarto del miocardio 87
null 85
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes. 83
Isolamento e caratterizzazione immunofenotipica di cellule non-emopoietiche presenti in versamenti ascitici e pleurici di pazienti con malattie ematologiche 82
Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy? 80
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia 80
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 79
Assessment of growth of endothelial cells and fibroblasts in long-term cultures of patients with haematological malignancies. 79
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen 78
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 77
null 77
Alloreactivity: the Janus-face of hematopoietic stem cell transplantation 76
Differences among young adults, adults and elderly chronic myeloid leukemia patients 76
Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: A retrospective study from the European Society for Blood and Marrow Transplantation database 75
Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT) 75
Citometria a flusso: applicazioni in ematologia 75
Adverse haematological effects of ticlopidine. A report of four cases 74
Bone marrow stromal cells in acute promyelocytic leukaemia: comparison with other acute myelogenous leukaemia subtypes. 74
Post-thaw viability of cryopreserved peripheral blood stem cells: what are we actually looking at? 74
Assessment of bone marrow-derived endothelial cells in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation 73
Absence of HTLV-1 in myelodysplastic syndromes in an area non endemic for HTLV-1 infection. 71
null 71
Move on air: Webinar for education in stem cells mobilization Report I 70
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study 69
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry 69
p53 exon 5 mutation in two cases of leukemic mantle cell lymphoma 68
Novel Applications for the Flow Cytometry 68
Photomultiplier voltage setting: Possible important source of variability in molecular equivalents of soluble fluorochrome (MESF) calculation? 67
In vitro expansion and immunophenotypic characterization of circulating stem celle in patients affected by systemic scleoris (SSc): possible implications in fibrosis process 67
Sources and procurements of HSC 67
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: A 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT) 67
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 65
Chlamydia trachomatis and Ocular Lynphoma. a possible link? 64
Is allogeneic transplant for solid tumors still alive? 64
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 64
Trapianto autologo di cellule staminali in paziente affetta da sclerosi sistemica a varietà diffusa. 63
Long term cultured bone marrow cell from multiple myloma patients give rise to higher number of endothelial colonies than MGUS patients and normal controls 63
Human bone marrow endothelial-colony growth before and after stem cell transplantation in non-hodgkin’s lymphoma patients. 63
Hematopoietic SCT in Europe 2013: Recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants 63
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 63
Hematopoietic stem cell transplantation in Europe 2014: More than 40 000 transplants annually 62
null 61
Correlation between doses of CD34+ cell subsets infused, number of long-term culture colony forming cells and kinetics of engrafment in patients receiving autologous peripheral blood stem cell transplant 61
Eterogeneita’ immunofenotipica di cellule staminali mesenchimali dopo espansione ex vivo 61
Cellule mesenchimali stromali: caratterizzazione immunofenotipica e funzionale 61
Multicolor analysis of bone marrow stromal cells from normal and leukemic patients 60
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 60
Use of haploidentical stem cell transplantation continues to increase: The 2015 European Society for Blood and Marrow Transplant activity survey report 60
Factors affecting successful mobilization with plerixafor: An Italian prospective survey in 215 patients with multiple myeloma and lymphoma 60
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model 60
Presenza di molecole solubili HLA-G nel plasma da cordone ombelicale: un possibile marcatore di tolerogenicità? 59
Production of solubile HLA-G antigens by bone marrow - derived human mesenchimal cells (B-MSCS) has a role in the inhibition of the lymphoproliferative response. 58
Cytofluorimetric analysis of cytokine receptors in blast cells from acute leukemia. 58
Development of adaptive immune effector therapies in solid tumors 58
Cellule staminali circolanti in pazienti con infarto miocardico. 57
Production of soluble HLA-G antigens is involved in the inhibition of lymphoproliferative response by human mesenchymal stromal cells (MSC) from different sources 57
Totale 9.126
Categoria #
all - tutte 98.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.448
Totale 101.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.325 0 0 0 227 89 216 118 183 583 482 278 149
2020/20214.512 332 356 315 315 361 521 180 437 112 722 666 195
2021/20222.419 198 348 74 131 75 80 123 169 110 284 151 676
2022/20231.650 306 54 71 265 216 207 55 144 177 21 84 50
2023/2024868 87 89 61 35 52 67 25 50 27 18 34 323
2024/2025765 159 55 481 70 0 0 0 0 0 0 0 0
Totale 15.725